PDSS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.062200E-01
Normal-vs-Stage2
4.871200E-01
Normal-vs-Stage3
9.986500E-02
Normal-vs-Stage4
6.464200E-01
Stage1-vs-Stage2
2.134000E-01
Stage1-vs-Stage3
1.456960E-01
Stage1-vs-Stage4
5.133200E-01
Stage2-vs-Stage3
1.027360E-01
Stage2-vs-Stage4
6.813600E-01
Stage3-vs-Stage4
2.381800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.359600E-01
Normal-vs-AfricanAmerican
8.608200E-01
Normal-vs-Asian
2.826000E-01
Caucasian-vs-AfricanAmerican
2.624800E-01
Caucasian-vs-Asian
3.985600E-01
AfricanAmerican-vs-Asian
8.232100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.139000E-01
Normal-vs-Female
6.847000E-01
Male-vs-Female
1.933760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.392800E-01
Normal-vs-Age(41-60Yrs)
6.906200E-01
Normal-vs-Age(61-80Yrs)
4.518600E-01
Normal-vs-Age(81-100Yrs)
7.977800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.928000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.954800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.581200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.792760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.142600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.163600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.549600E-01
Normal-vs-Daily Drinker
1.240820E-01
Normal-vs-Weekly Drinker
6.190000E-01
Normal-vs-Occasional Drinker
6.273400E-01
Normal-vs-Social Drinker
7.738600E-01
Non Drinker-vs-Daily Drinker
2.868000E-01
Non Drinker-vs-Weekly Drinker
6.979800E-01
Non Drinker-vs-Occasional Drinker
6.899200E-01
Non Drinker-vs-Social Drinker
3.901200E-01
Daily Drinker-vs-Weekly Drinker
3.055600E-01
Daily Drinker-vs-Occasional Drinker
2.751800E-01
Daily Drinker-vs-Social Drinker
1.548030E-01
Weekly Drinker-vs-Occasional Drinker
9.987000E-01
Weekly Drinker-vs-Social Drinker
7.365400E-01
Occasional Drinker-vs-Social Drinker
7.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.331230E-01
Normal-vs-Grade 2
1.374230E-01
Normal-vs-Grade 3
1.427390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.233400E-01
Grade 1-vs-Grade 3
6.463400E-01
Grade 1-vs-Grade 4
1.331230E-01
Grade 2-vs-Grade 3
4.384600E-01
Grade 2-vs-Grade 4
1.374230E-01
Grade 3-vs-Grade 4
1.427390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.589000E-01
Normal-vs-NonDiabetic
4.479200E-01
Diabetic-vs-NonDiabetic
2.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.791400E-01
Normal-vs-NoPancreatitis
4.687000E-01
Pancreatitis-vs-NoPancreatitis
6.194000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.840600E-01
Normal-vs-N1
4.617800E-01
N0-vs-N1
5.708600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.387200E-01
Normal-vs-TP53-NonMutant
9.235200E-01
TP53-Mutant-vs-TP53-NonMutant
3.986100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
